- ASO Visual Abstract: Incidence of Occult Breast Cancer in Carriers of BRCA1/2 and Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy-When is Sentinel Lymph Node Biopsy Indicated?
- Wong SM, Ferroum A, Apostolova C, Alhassan B, Prakash I, Basik M, Boileau JF, Meterissian S, Aleynikova O, Wong N, Foulkes WD.
- Ann Surg Oncol. 2022 Jul 8. doi: 10.1245/s10434-022-12011-3. Epub ahead of print.
- PMID: 35802212
- PubMed abstract
- Source abstract
- Triple therapy in biliary tract cancers: GemOX plus immune checkpoint inhibitor in combination with lenvatinib or NGS-guided targeted therapy.
- Dong X, Zhang Z, Zhang Q, Chen L, Cao G, Liu C, Song T, Lu W, Zhang W.
- Cancer Res Clin Oncol. 2022 Jul 8. doi: 10.1007/s00432-022-04166-z. Epub ahead of print.
- PMID: 35802197
- PubMed abstract
- Source abstract
- Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from Pakistan.
- Rashid MU, Muhammad N, Shehzad U, Khan FA, Loya A, Hamann U.
- Fam Cancer. 2022 Jul 8. doi: 10.1007/s10689-022-00304-1. Epub ahead of print.
- PMID: 35802266
- PubMed abstract
- Source abstract
- Current and New Novel Combination Treatments for Metastatic Triple-Negative Breast Cancer.
- Pauls M, Chia S, LeVasseur N.
- Curr Oncol. 2022 Jul 7;29(7):4748-4767. doi: 10.3390/curroncol29070377.
- Review
- Free Full Text
- Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas.
- Menghi R, Banda K, Kumar P, Straub R, Dobrolecki L, Rodriguez IV, Yost SE, Chandok H, Radke MR, Somlo G, Yuan Y, Lewis MT, Swisher EM, Liu ET.
- Sci Transl Med. 2022 Jul 6;14(652):eabn1926. doi: 10.1126/scitranslmed.abn1926.
Research news: Breast, Ovarian Cancer Study Finds Ties Between Types of BRCA Alterations, Treatment Response. (Precision Oncology News)